ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Valneva SE

Valneva SE (VLA)

2,728
0,268
(10,89%)
Geschlossen 02 Februar 5:30PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
2,728
Gebot
2,70
Fragen
2,74
Volumen
4.717.102
2,534 Tagesbereich 2,82
1,726 52-Wochen-Bereich 4,298
Marktkapitalisierung
Handelsende
2,46
Handelsbeginn
2,536
Letzte Trade
221
@
2.728
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
842.385
Ausgegebene Aktien
138.202.132
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,72
Gewinn pro Aktie (EPS)
-0,73
Erlöse
175,73M
Nettogewinn
-101,43M

Über Valneva SE

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Saint-herblain, Loire-atlantique, Fra
Gegründet
-
Valneva SE is listed in the Pharmaceutical Preparations sector of the Euronext with ticker VLA. The last closing price for Valneva was 2,46 €. Over the last year, Valneva shares have traded in a share price range of 1,726 € to 4,298 €.

Valneva currently has 138.202.132 shares in issue. The market capitalisation of Valneva is 339,98 € million. Valneva has a price to earnings ratio (PE ratio) of -3.72.

VLA Neueste Nachrichten

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million 

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million  Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA...

Valneva annonce un nouveau contrat d’une valeur minimale de $32.8 millions avec le gouvernement américain pour la fourniture de son vaccin IXIARO®

Valneva annonce un nouveau contrat d’une valeur minimale de $32.8 millions avec le gouvernement américain pour la fourniture de son vaccin IXIARO® Saint Herblain (France), le 30 janvier 2025 –...

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million 

Saint Herblain (France), January 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United...

Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision

Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision Saint-Herblain (France), January 22, 2025 – Valneva SE (Nasdaq: VALN; Euronext...

Valneva annonce des résultats de Phase 2 positifs chez les enfants pour son vaccin contre le chikungunya ainsi que la dose sélectionnée pour la Phase 3

Valneva annonce des résultats de Phase 2 positifs chez les enfants pour son vaccin contre le chikungunya ainsi que la dose sélectionnée pour la Phase 3 Saint-Herblain (France), le 22 janvier 2025...

Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision

Saint-Herblain (France), January 22, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive results for its Phase 2 clinical trial evaluating the safety and immunogenicity...

Valneva annonce une réponse immunitaire robuste et durable chez les adolescents un an après une seule vaccination avec son vaccin contre le chikungunya

Valneva annonce une réponse immunitaire robuste et durable chez les adolescents un an après une seule vaccination avec son vaccin contre le chikungunya Saint-Herblain (France), le 20 janvier 2025...

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine Saint-Herblain (France), January 20, 2025 – Valneva SE (Nasdaq: VALN;...

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine

Saint-Herblain (France), January 20, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its...

Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference

Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference Saint Herblain (France), le 6 janvier 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.4318.71192341172.2982.822.2028895932.35404233DE
40.36815.5932203392.362.822.057654652.25376402DE
120.218.339952343132.5182.821.7268423852.08479196DE
26-0.588-17.73220747893.3163.931.7266816202.48171297DE
52-1.022-27.25333333333.754.2981.7266087262.96663552DE
156-12.342-81.89781021915.0718.921.7265270176.64190807DE
260-0.382-12.28295819943.1129.71.72670508010.63157964DE

VLA - Frequently Asked Questions (FAQ)

What is the current Valneva share price?
The current share price of Valneva is 2,728 €
How many Valneva shares are in issue?
Valneva has 138.202.132 shares in issue
What is the market cap of Valneva?
The market capitalisation of Valneva is EUR 339,98M
What is the 1 year trading range for Valneva share price?
Valneva has traded in the range of 1,726 € to 4,298 € during the past year
What is the PE ratio of Valneva?
The price to earnings ratio of Valneva is -3,72
What is the cash to sales ratio of Valneva?
The cash to sales ratio of Valneva is 2,15
What is the reporting currency for Valneva?
Valneva reports financial results in EUR
What is the latest annual turnover for Valneva?
The latest annual turnover of Valneva is EUR 175,73M
What is the latest annual profit for Valneva?
The latest annual profit of Valneva is EUR -101,43M
What is the registered address of Valneva?
The registered address for Valneva is 6 RUE ALAIN BOMBARD, CAMPUS BIO-OUEST, SAINT-HERBLAIN, LOIRE-ATLANTIQUE, 44800
What is the Valneva website address?
The website address for Valneva is www.valneva.com
Which industry sector does Valneva operate in?
Valneva operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ALCYBCybergun
0,0002 €
(100,00%)
63,2M
TUVDSBio UV Group DS
0,015 €
(70,45%)
490,92k
CANDCandela Invest
1,70 €
(70,00%)
42
BIODSBiosynex DS
0,07 €
(39,44%)
55,52k
ALGTRGroupe Tera SA
4,10 €
(25,77%)
17,71k
MLIMLImalliance
0,282 €
(-27,32%)
1,5k
ALCARCarmat
0,822 €
(-22,60%)
3,04M
MLOCTOctopus Biosafety
0,14 €
(-21,35%)
18,55k
ALEXPOne Experience
0,386 €
(-21,22%)
933
SNGSonagi
0,80 €
(-20,00%)
800
ATOAtos SE
0,0023 €
(4,55%)
608,11M
ALVERVergnet
0,0011 €
(0,00%)
92,88M
ALCYBCybergun
0,0002 €
(100,00%)
63,2M
BCPBanco Comercial Portugues SA
0,5054 €
(0,04%)
32,95M
ALHPIHopium SA
0,0028 €
(-6,67%)
15,99M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock